Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Figures and Graphics
Borchard U  
The Role of the Sympathetic Nervous System in Cardiovascular Disease

Journal of Clinical and Basic Cardiology 2001; 4 (3): 175-177

PDF    Summary    Figures   


Figure
 
Framingham - Herzfrequenz
Figure 1: Increase in heart rate is correlated to mortality due to coronary heart disease (CHD), cardiovascular disease or all causes (modified according to [2])


Keywords: DiagrammFramingham-StudieFramingham-Studieheart rateHerzfrequenzStudiestudy
 
 
SNS-Überaktivität - kardiovaskuläre Erkrankung
Figure 2: Sustained SNS overactivity induces functional and structural changes of different organs leading to cardiovascular diseases.


Keywords: cardiovascular diseasekardiovaskuläre ErkrankungSchemasympathetic nervous systemSympathikussympathisches NervensystemÜberaktivität
 
 
SNS-Überaktivität - Hypertrophie
Figure 3: From hypertension to heart failure: SNS overactivity leads to an increase in growth factors responsible for left ventricular hypertrophy, media hypertrophy (coronary microvessels) and fibrosis. The result may be heart failure.


Keywords: HypertrophieHypertrophyoveractivitySchemasympathetic nervous systemSympathikussympathisches NervensystemventricleVentrikelÜberaktivität
 
 
SNS-Überaktivität - Metabolismus
Figure 4: Metabolic changes due to elevated sympathetic tone: SNS overactivity leads to increased glucose production, decreased glucose utilization, increase in triglycerides and VLDL, decrease in HDL and insulin resistance (metabolic syndrome).


Keywords: CholesterincholesterolHDLHDLinsulin resistanceInsulinresistenzmetabolismMetabolismusoveractivitySchemasympathetic nervous systemSympathikussympathisches NervensystemtriglycerideTriglyzerideVLDLVLDLÜberaktivität
 
 
Moxonidin - Imidazolinrezeptor
Figure 5: Moxonidine selectively stimulates I1-receptors in the rostral ventrolateral medulla (RVLM). The sympathetic outflow from the RVLM to the periphery is decreased.


Keywords: ImidazolinImidazolineMedullaMedullaMoxonidinmoxonidineReceptorRezeptorSchemaStimulationStimulation
 
 
Imidazolinantagonisten
Figure 6: There is a strong correlation between the affinity of different I1-agonists at the I1-receptor in the ventrolateral medulla (VLM) and the oral dose needed to lower blood pressure in hypertensive patients. There is no such correlation for Ki at a2-receptors (modified according to [15])


Keywords: AntagonistAntagonistblood pressureBlutdruckClonidinDiagrammhypertensionHypertonieImidazolinImidazolineLofexidinMedullaMedullaMoxonidinReceptorRezeptorRilmenidin
 
 
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung